Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Imfinzi approved in China for the treatment of unresectable, Stage III non-small cell lung cancer based on the Phase III PACIFIC trial
-
Trastuzumab deruxtecan achieved a tumour response rate of 60.9% in pivotal Phase II HER2-positive metastatic breast cancer trial
-
Calquence significantly prolonged the time patients lived without disease progression or death in previously untreated chronic lymphocytic leukaemia
-
Calquence significantly prolonged the time patients lived without disease progression or death in previously untreated chronic lymphocytic leukaemia
-
Lynparza approved in China as a 1st-line maintenance therapy in BRCA-mutated advanced ovarian cancer
-
AstraZeneca divests rights to Seroquel and Seroquel XR in the US and Canada
-
Imfinzi granted FDA Priority Review for the treatment of patients with extensive-stage small cell lung cancer
-
Calquence approved in the US for adult patients with chronic lymphocytic leukaemia
-
Harvard Business Review names Pascal Soriot among ‘Best Performing Top 100 CEOs in the World’ 2019
-
Qtrilmet approved in the EU for the treatment of type-2 diabetes
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
